# Oral Versus Intravenous Magnesium on Emergence Delirium

> **NCT07655817** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 360 (estimated)

## Conditions studied

- Magnesium
- Emergence Delirium
- Children
- Adenotonsillectomy

## Interventions

- **DRUG:** Magnesium glycinate
- **DRUG:** Magnesium sulfate injection
- **OTHER:** Oral juice and intravenous saline

## Key facts

- **NCT ID:** NCT07655817
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-12-24
- **Final completion:** 2026-12-25
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655817, "Oral Versus Intravenous Magnesium on Emergence Delirium". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*